CXCR2 Leucocyte Expression Level as a Predictive Factor of Coronary Artery Calcification Progression in Advanced Chronic Kidney Disease Patients | MicrobiomeTrials← Back to trialsNCT07811505
CXCR2 Leucocyte Expression Level as a Predictive Factor of Coronary Artery Calcification Progression in Advanced Chronic Kidney Disease Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2029-08
Enrollment target: 100 participants Locations- CHRU Amiens, Amiens, France
Other microbiome trials you might be interested in
Chronic Kidney Disease Stage 5End Stage Renal Disease
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care wi…
Winnipeg, CanadaEst. completion Mar 30, 2027
Hepatitis DHepatitis CHepatitis BLiver Disease
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease.…
Bethesda, United States